56 search results for: chronic inflammation

UEG Upcoming Events Carousel Thumbnail
Congress
5
October
2025
Congress
ADVENT at UEG WEEK 2025 | Bridging the Gap in EoE: Innovative Strategies for Seamless Transition of Care

Join Thomas Greuter, MD, Edoardo Vincenzo Savarino, MD, PhD, and Carla Giordano, MD, PhD, for an educational symposium as they use a case-based approach to explore the impact of chronic type 2 inflammation in EoE and outline strategies for optimizing transition of care and monitoring disease progression.

Join experts Prof. Salvatore Oliva and Dr. Milli Gupta for an educational symposium on the on type 2 inflammation in EoE.
On Demand
UEGW 2024 | Something to Chew On: Exploring Biologics in EoE Management

Prof. Salvatore Oliva and Dr. Milli Gupta discuss the importance of long-term care, multidimensional assessment, and the latest data for biologics.

European Society for Pediatric Dermatology (ESPD) 2024 | Košice, Slovakia
Congress
3
May
2024
Congress
European Society for Pediatric Dermatology (ESPD) 2024 | Košice, Slovakia

Inflammatory processes drive AD both within and beyond the skin, leading to significant, cumulative life impacts. Early intervention has the potential to mitigate these impacts by altering the disease course.

ESPGHAN 2024 | Burden and Timely Recognition of Pediatric EoE
Gastroenterology
ESPGHAN 2024 | Burden and Timely Recognition of Pediatric EoE
expert video

Dr. Dhandapani Ashok discusses patient and caregiver burden in pediatric EoE and the challenges with identifying EoE in a young patient population.

View more
Itch in <b>Chronic</b> Inflammatory Skin Diseases: Histaminergic and Nonhistaminergic Mechanisms and Role of IL-4 as a Central Orchestrator in Promoting Neuronal Sensitization
Type 2 Inflammation
Itch in Chronic Inflammatory Skin Diseases: Histaminergic and Nonhistaminergic Mechanisms and Role of IL-4 as a Central Orchestrator in Promoting Neuronal Sensitization
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Dr. Brian Kim explores the histaminergic and nonhistaminergic mechanisms of itch, highlighting how type 2 cytokines like IL-4 serve as central orchestrators of neuronal sensitization and immune–nervous system cross-talk.

View more
ADVENT at ERS-ISIAN 2025
On Demand
ERS-ISIAN 2025 | Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions

In this educational presentation, Profs. Vibeke Backer and Sietze Reitsma cover key aspects of type 2 inflammation and its role in the pathogenesis and management of CRSwNP and practical strategies for optimizing disease control and improving patient outcomes.

EAACI 2022 | Hard to Swallow: Identifying and Managing EoE in the Allergy Clinic
Gastroenterology
EAACI 2022 | Hard to Swallow: Identifying and Managing EoE in the Allergy Clinic
expert video

Experts Prof. Ingrid Terreehorst and Prof. Arjan Bredenoord discuss the allergist’s perspective on identifying and management of patients with EoE.

View more
ADVENT On Air | Exploring The Urgency to Treat in Atopic Dermatitis
Dermatology
ADVENT On Air | Exploring The Urgency to Treat in Atopic Dermatitis
Podcast

Professor Lisa Beck explores the chronic and persistent burden of atopic dermatitis (AD) as well as the concept of early intervention in patients with AD.

View more
Digestive Disease Week 2024 | Washington D.C.
Awareness Day
18
May
2024
Awareness Day
Digestive Disease Week 2024 | Washington D.C.

Join ADVENT at the Digestive Disease Week 2024 Congress and visit the Sanofi and Regeneron Medical Booth # 1707.

How Does Protective Type 2 Immunity Become Harmful Type 2 <b>Inflammation</b>?
Dermatology
How Does Protective Type 2 Immunity Become Harmful Type 2 Inflammation?
expert video

In this video from the March 2025 ADVENT symposium in Orlando, Florida, Dr. Eric Simpson discusses how protective type 2 immunity can become dysregulated, leading to harmful type 2 inflammation. The associated inflammatory process can contribute to the pathophysiology of several dermatological diseases, including AD, PN, CSU, and BP.

View more
IFOS 2023 | Type 2 <b>Inflammation</b> and Clinically Relevant Improvements in CRSwNP
On Demand
IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP

Dr. Stella Lee and Profs. Peter Hellings and Wytske Fokkens discuss type 2 inflammation, partnering with patients to improve outcomes, and real-world data on biologic effectiveness in CRSwNP.